Ordinary hemangioma
Like a small, enclosed pouch of blood; most can subside with simple treatment
Minimally Invasive Care for Complex Vascular Malformations: Type-Specific Treatment by Liao Zhengyin’s MDT Team
-
4 categories
High-risk vascular malformationsComprehensive coverage
-
24h
High-risk shuntsTime to elimination
-
48h
MDT-signedDiagnosis and treatment report
SELF CHECK
Are you facing these moments of despair?
If any of these sound familiar, please read on
-
You have visited many hospitals, only to hear "It is too complex to treat" or "Surgical removal is the only option".
-
You have undergone interventional treatment or sclerotherapy, but your condition keeps worsening and recurring, with the vascular malformation returning aggressively.
-
A facial malformation affects your appearance, leaving you afraid to go out or socialize, while constantly worrying about severe bleeding.
-
Your doctor says the lesion must be removed extensively along with surrounding healthy tissue—an outcome you and your family cannot accept.
The "surgical no-go zones" others dare not touch Are precisely where we focus our efforts
WARNING
They may look alikeThe wrong treatment is like taking a scalpel to a bomb
Vascular malformations and ordinary hemangiomas are fundamentally different conditions
Complex vascular malformation
Like a network of misconnected water pipes; misguided treatment makes it more dangerous
Treating blindly only increases the danger
-
Blocking the wrong site
-
Blood flow balancecollapses instantly
-
Malformed vesselsrebound aggressively
- Mild
Accelerated facial collapse and disfigurement, causing irreversible damage to appearance
- Severe
Massive internal bleeding that can become life-threatening at any moment
- Critical
The heart is pushed toward failure, affecting multiple organs
Blocking vessels blindly without understanding blood flow does not defuse the bomb—it sets it off
WHY US
The same condition, dramatically different outcomes
Map blood flow before treatment—a tiny difference can mean life or death
| Conventional intervention | Liao Zhengyin MDT team |
|---|---|
| When treating small, superficial malformations, healthy vessels may be embolized by mistake, causing disfigurement | Treat cranial and pelvic AVMs with superselective embolization, preserving facial appearance and organ function |
| Blind embolization of arteriovenous fistulas can cause fatal pulmonary embolism | Precisely occlude high-flow AV fistulas to reverse the progression of heart failure |
| Unable to manage diffuse venous malformations, with recurrence despite repeated injections | Combine percutaneous sclerotherapy under dual guidance with minimally invasive debulking to restore appearance |
| Failure to distinguish KTS from Parkes Weber syndrome may lead to unnecessary amputation | Use MDT differential diagnosis to identify the condition, block abnormal return flow and preserve limb function |
TREATMENT
Four high-risk shunt types, targeted treatment for each
A "shunt" is an abnormal passage in the vascular systemOne strategy per type · Core strategies for elimination within 24 hours
Life-threatening high-flow shunts
Risk of death- Mechanism
- Arterial blood flows directly through the malformation nidus into veins → cardiac volume overload → progressive heart failure
- Conditions
- Cranial AVM · Pelvic AVM · High-flow AV fistulas
- Strategy
- Destroy the nidus (ablation with absolute ethanol) · Cut off supply (embolization of feeding arteries through multiple routes) · Isolate the fistula (exclude its opening with a covered stent)
- Expected results
- Significantly reduced cardiac workload and restored organ perfusion
Extensive low-flow shunts
Disfigurement risk- Mechanism
- Persistent blood leakage and fluid accumulation in a diffuse abnormal vascular bed → progressive local swelling and disfigurement
- Conditions
- Diffuse venous malformations of the face and neck · Blue rubber bleb nevus · Giant cystic lymphatic malformations
- Strategy
- Dual-guided targeting (precise puncture under combined ultrasound/MRI guidance) + Sclerotic closure (intralesional sclerotherapy combined with minimally invasive debulking)
- Expected results
- Bleeding stops completely and normal appearance is restored
Mixed-type shunts
Multisystem involvement- Mechanism
- Simultaneous involvement of arterial, venous and lymphatic systems → progressive limb overgrowth and deformity
- Conditions
- CVM · CLVM (with soft tissue/bone overgrowth)
- Strategy
- Layered treatment: ① Embolize the arterial supply ② Sclerose venous lakes ③ Suppress lymphatic microcysts
- Expected results
- Enlarged limbs become noticeably slimmer and free movement is restored
Syndromic high-risk shunts
Often missed or misdiagnosed- Mechanism
- Genetic mutations combined with hemodynamic disturbances → progressive multisystem deterioration
- Conditions
- KTS · Parkes Weber · PTEN hamartoma · CLOVES
- Strategy
- Treat the cause and its effects: Gene-targeted drugs to control the underlying cause + hemodynamic correction + sequential MDT management
- Expected results
- Preserve limbs and life, avoiding amputation and sudden death
ADVANTAGES
Liao Zhengyin MDT team: four core strengths
Liao Zhengyin Professor · PhD
A leading figure in multidisciplinary care for complex tumors in China
Former Director of the Cancer Center at West China Hospital · First-tier specialist
“ With complex vascular malformations, the issue is not "untreatable", but "not yet clearly understood"—once blood flow is fully understood, a no-go zone becomes a path forward. ”
-
Map the vessels before treatment
Trace blood flow from source to destination before the procedure
-
Superselective embolization targets only the lesion
Spare healthy vessels, preserving facial appearance and organs
-
One plan developed by the MDT
Specialists consult across disciplines to eliminate diagnostic errors
-
Specialists in "no-go zone" cases
Cases others hesitate to accept are routine here
CASES
They were once told "nothing could be done"
These cases come from actual clinical recordsFor each patient told "nothing could be done", the story continued here
Arteriovenous malformation of the lip (Case 1)
57-year-old man / Left upper lip AVM (Yakes type IV)
- Background:
- A pulsatile mass on the left upper lip had been present for years, with recurrent bleeding. Several hospitals recommended surgical excision, noting the risks of lip tissue loss and impaired appearance and function.
- Treatment:
- Interventional sclerotherapy and ablation with absolute ethanol (superselective embolization of a Yakes type IV AVM)
- Outcome:
- At 1-year follow-up, swelling and pulsation had resolved, with the lip contour preserved.
Arteriovenous malformation of the lip (Case 2)
38-year-old woman / Left lower lip AVM
- Background:
- Progressive thickening of the left lower lip was accompanied by local pulsation and recurrent oral bleeding over several years. Another hospital recommended en bloc excision with immediate reconstructive surgery; the patient and her family declined this approach.
- Treatment:
- Percutaneous direct puncture of the abnormal vascular network + targeted embolization with absolute ethanol
- Outcome:
- Two months after treatment, abnormal local pulsation had resolved, with lip shape preserved and normal eating and speech.
Complex craniofacial arteriovenous malformation
Complex craniofacial AVM / Unsuccessful attempts to obtain treatment at multiple centers
- Background:
- The patient sought care at several medical centers for a complex craniofacial AVM. Each considered definitive treatment difficult because of the deep location and extensive involvement. Daily activities were substantially limited, and the platelet count was low.
- Treatment:
- Staged treatment with repeated transarterial embolization + direct-puncture ablation with absolute ethanol
- Outcome:
- Angiography showed occlusion of the main abnormal vascular nidus, with marked symptom improvement and no further recurrent bleeding.
Arteriovenous malformation of the forehead
Forehead AVM / Recurrence after surgery
- Background:
- A female patient with a forehead AVM had undergone surgical excision with poor results and residual scarring. Follow-up examination showed that the abnormal vascular network remained active, with a risk of ulceration and massive bleeding.
- Treatment:
- Superselective transarterial embolization + direct-puncture sclerotherapy (performed carefully to avoid feeding branches of the ophthalmic artery)
- Outcome:
- The bleeding risk resolved, the lesion shrank substantially, and both scarring and appearance improved.
These cases are drawn from actual clinical records of Professor Liao Zhengyin’s team and are provided for medical education and general health information only.
PROCESS
Consult online in three steps before visiting the hospital
Whether you are in China or abroadGet expert medical advice first, then decide whether to travel
-
Free consultation
Submit your medical information online. Our specialist team completes an assessment within 30 minutes to tell you whether minimally invasive treatment is suitable for you.
-
Upload your scans
Submit original CT, MRI or other imaging online. Scans from overseas are also accepted for joint review by our multidisciplinary MDT team.
-
Receive a signed report within 48 hours
Treatment plan · Risk management plan · Cost estimate, issued and signed by Professor Liao Zhengyin’s team.
Review the report before deciding to visit—patients in China and abroad can avoid an unnecessary trip
FAQ
Before you visit, understand these three things
Other hospitals said my condition cannot be treated. Can you really treat it?
Complex cases that other hospitals hesitate to accept are part of our everyday practice: cranial and pelvic AVMs, high-flow AV fistulas, KTS and related conditions are routinely treated here. Start with a free online consultation. After assessment, our MDT team will explain whether treatment is possible and how it would be carried out. Confirm suitability before traveling, so you avoid an unnecessary trip.
Could minimally invasive treatment cause disfigurement or damage my organs?
Quite the opposite. The principle of superselective embolization is to "target only abnormal vessels while sparing healthy ones". Preserving facial appearance and organ function is the main distinction between our approach and conventional intervention.
I live in another city or overseas. How can a specialist review my scans first?
Simply submit your original CT, MRI or other imaging online; scans from overseas are also accepted. Within 48 hours, you will receive a report signed by Professor Liao Zhengyin’s team covering your treatment plan, risk management plan and cost estimate. Review it before deciding whether to visit.
Weekly MDT consultation slots are limited · Submit early for an earlier appointment
Do not let "untreatable" be the final answer
Start with a free consultation and receive a signed report within 48 hoursWhether treatment is possible, how it works and the estimated cost—all explained clearly
Free medical record review · Book our expert teamMany patients once told "nothing can be done" have found a turning point here
